These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 5697336)

  • 21. [Platelet aggregate formation in peripheral blood anti-coagulated with sodium heparin is facilitated by mixing].
    Shimasaki AK; Ozaki Y
    Rinsho Ketsueki; 1997 Apr; 38(4):323-30. PubMed ID: 9146062
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Determinants of donor platelet variability when testing for heparin-induced thrombocytopenia.
    Warkentin TE; Hayward CP; Smith CA; Kelly PM; Kelton JG
    J Lab Clin Med; 1992 Sep; 120(3):371-9. PubMed ID: 1517683
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-associated thrombocytopenia.
    Cines DB; Kaywin P; Bina M; Tomaski A; Schreiber AD
    N Engl J Med; 1980 Oct; 303(14):788-95. PubMed ID: 7412786
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet counts in capillary blood.
    Feusner JH; Behrens JA; Detter JC; Cullen TC
    Am J Clin Pathol; 1979 Sep; 72(3):410-4. PubMed ID: 112854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying patients at high risk of heparin-induced thrombocytopenia-associated thrombosis with a platelet activation assay using flow cytometry.
    Maeda T; Nakagawa K; Murata K; Kanaumi Y; Seguchi S; Kawamura S; Kodama M; Kawai T; Kakutani I; Ohnishi Y; Kokame K; Okazaki H; Miyata S
    Thromb Haemost; 2017 Jan; 117(1):127-138. PubMed ID: 27734072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Absolute immature platelet counts in the setting of suspected heparin-induced thrombocytopenia may predict anti-PF4-heparin immunoassay testing results.
    Chen W; Ha JP; Hong H; Maitta RW
    Transfus Apher Sci; 2018 Aug; 57(4):507-511. PubMed ID: 29661682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparin-associated thrombocytopenia: low frequency in 104 patients treated with heparin of intestinal mucosal origin.
    Malcolm ID; Wigmore TA; Steinbrecher UP
    Can Med Assoc J; 1979 May; 120(9):1086-8. PubMed ID: 571755
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Heparin and blood platelets].
    Komarnicki M; Kaźmierczak M
    Pol Tyg Lek; 1989 Oct 2-16; 44(40-42):899-901. PubMed ID: 2487948
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of platelet antiserum on the precipitation of soluble fibrin by endotoxin.
    Müller-Berghaus G; Kramer W
    Thromb Haemost; 1976 Feb; 35(1):237-48. PubMed ID: 989190
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Platelet response to direct thrombin inhibitor or fondaparinux treatment in patients with suspected heparin-induced thrombocytopenia.
    Pon TK; Mahajan A; Rosenberg A; Amin A; Shah D; Jenkins I; Gupta V; Hofmann H; Bejjani A; White R
    J Thromb Thrombolysis; 2018 May; 45(4):536-542. PubMed ID: 29574610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of heparin vs. citrate on the interaction of platelets with vascular graft materials.
    Kottke-Marchant K; Anderson JM; Rabinovitch A; Huskey RA; Herzig R
    Thromb Haemost; 1985 Dec; 54(4):842-8. PubMed ID: 2935968
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of small doses of heparin on platelet adhesiveness and lipoprotein-lipase activity before and after operation.
    Ham JM; Slack WW
    Br J Surg; 1968 Mar; 55(3):227-30. PubMed ID: 5637098
    [No Abstract]   [Full Text] [Related]  

  • 33. Incidence and prognostic significance of thrombocytopenia in patients treated with prolonged heparin therapy.
    Oliveira GB; Crespo EM; Becker RC; Honeycutt EF; Abrams CS; Anstrom KJ; Berger PB; Davidson-Ray LD; Eisenstein EL; Kleiman NS; Moliterno DJ; Moll S; Rice L; Rodgers JE; Steinhubl SR; Tapson VF; Ohman EM; Granger CB;
    Arch Intern Med; 2008 Jan; 168(1):94-102. PubMed ID: 18195201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A modification of the technique for 51Cr-labelling of blood platelets giving increased circulating platelet radioactivity.
    Abrahamsen AF
    Scand J Haematol; 1968; 5(1):53-63. PubMed ID: 5665819
    [No Abstract]   [Full Text] [Related]  

  • 35. Thrombocytopenia found uncommonly during heparin therapy.
    Powers PJ; Cuthbert D; Hirsh J
    JAMA; 1979 Jun; 241(22):2396-7. PubMed ID: 571485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet consumption by polyvinyl alcohol coated tubing in canines.
    Ip WF; Sefton MV
    J Biomed Mater Res; 1991 Jul; 25(7):875-87. PubMed ID: 1918104
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro efficacy of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia.
    Mak KH; Kottke-Marchant K; Brooks LM; Topol EJ
    Thromb Haemost; 1998 Dec; 80(6):989-93. PubMed ID: 9869172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective effect of pantethine on experimental thrombocytopenia in the rat.
    Ashida SI; Abiko Y
    Thromb Diath Haemorrh; 1975 Jun; 33(3):528-39. PubMed ID: 1154310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of heparin on the platelet count in vitro, with particular reference to the collection of blood for extracorporeal circulation.
    PERKINS HA; OSBORN JJ; GERBODE F
    Am J Clin Pathol; 1958 Nov; 30(5):397-403. PubMed ID: 13594909
    [No Abstract]   [Full Text] [Related]  

  • 40. Scanning electron microscopic observations of the common carotid artery of the rat. III. Heparin effect on platelets.
    Gregorius FK; Rand RW
    Surgery; 1976 May; 79(5):584-9. PubMed ID: 1265668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.